{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:43:45Z","timestamp":1791413025346,"version":"4.3.3"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T00:00:00Z","timestamp":1100044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s00109-004-0591-7","type":"journal-article","created":{"date-parts":[[2004,11,9]],"date-time":"2004-11-09T10:48:57Z","timestamp":1099997337000},"page":"787-799","source":"Crossref","is-referenced-by-count":71,"title":["The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine"],"prefix":"10.1007","volume":"82","author":[{"given":"Edward M.","family":"Mills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Rusyniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon E.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,11,10]]},"reference":[{"key":"CR1","first-page":"70","volume":"5","author":"Farley","year":"2000","unstructured":"Farley C J (2000) Rave new world. Time 5:70?72","journal-title":"Time"},{"key":"CR2","doi-asserted-by":"crossref","unstructured":"Green AR, Cross AJ, Goodwin GM (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or ?ecstasy?). Psychopharmacology (Berl) 119:247?260","DOI":"10.1007\/BF02246288"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"Green","year":"2003","unstructured":"Green AR, Mechan AO, Elliott JM, O?Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?). Pharmacol Rev 55:463?508","journal-title":"Pharmacol Rev"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jama.1987.03400060056021","volume":"258","author":"Brown","year":"1987","unstructured":"Brown C, Osterloh J (1987) Multiple severe complications from recreational ingestion of MDMA (?ecstasy?). JAMA 258:780?781","journal-title":"JAMA"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.1987.03390120077027","volume":"257","author":"Dowling","year":"1987","unstructured":"Dowling GP, McDonough ET, Bost RO (1987) ?Eve? and ?ecstasy?. A report of five deaths associated with the use of MDEA and MDMA. JAMA 257:1615?1617","journal-title":"JAMA"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00007611-199103000-00015","volume":"84","author":"Chadwick","year":"1991","unstructured":"Chadwick IS, Curry PD, Linsley A, Freemont AJ, Doran B (1991) Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med 84:371","journal-title":"J R Soc Med"},{"key":"CR7","first-page":"61","volume":"85","author":"Campkin","year":"1992","unstructured":"Campkin NT, Davies UM (1992) Another death from ecstacy. J R Soc Med 85:61","journal-title":"J R Soc Med"},{"key":"CR8","doi-asserted-by":"crossref","unstructured":"Henry JA (1992) Ecstasy and the dance of death. BMJ 305 5?6","DOI":"10.1136\/bmj.305.6844.5"},{"key":"CR9","doi-asserted-by":"crossref","unstructured":"Henry JA, Jeffreys KJ, Dawling S (1992) Toxicity and deaths from 3,4-methylenedioxymethamphetamine. Lancet 340 384?387","DOI":"10.1016\/0140-6736(92)91469-O"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/014107689308600420","volume":"86","author":"Barrett","year":"1993","unstructured":"Barrett PJ, Taylor GT (1993) Ecstasy? ingestion: a case report of severe complications. J R Soc Med 86:233?234","journal-title":"J R Soc Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1476-5381.1995.tb15037.x","volume":"115","author":"Colado","year":"1995","unstructured":"Colado MI, Williams JL, Green AR (1995) The hyperthermic and neurotoxic effects of ?ecstasy? (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br J Pharmacol 115:1281?1289","journal-title":"Br J Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"51P","DOI":"10.1177\/014107689608900115","volume":"89","author":"Coore","year":"1996","unstructured":"Coore JR (1996) A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine\/3,4-methylenedioxyamphetamine toxicity. J R Soc Med 89:51P?52P","journal-title":"J R Soc Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/BF02044131","volume":"22","author":"Dar","year":"1996","unstructured":"Dar KJ, McBrien ME (1996) MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Med 22:995?996","journal-title":"Intensive Care Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00002826-199619020-00004","volume":"19","author":"Demirkiran","year":"1996","unstructured":"Demirkiran M, Jankovic J, Dean JM (1996) Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome. Clin Neuropharmacol 19:157?164","journal-title":"Clin Neuropharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.5694\/j.1326-5377.1996.tb122252.x","volume":"164","author":"Dowsett","year":"1996","unstructured":"Dowsett R P (1996) Deaths attributed to ?ecstasy? overdose. Med J Aust 164:700","journal-title":"Med J Aust"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/emj.14.3.183","volume":"14","author":"Cooper","year":"1997","unstructured":"Cooper AJ, Egleston CV (1997) Accidental ingestion of ecstasy by a toddler: unusual cause for convulsion in a febrile child. Emerg Med J 14:183?184","journal-title":"Emerg Med J"},{"key":"CR17","doi-asserted-by":"crossref","unstructured":"Gillman PK (1997) Ecstasy, serotonin syndrome and the treatment of hyperpyrexia. Med J Aust 167:109:111","DOI":"10.5694\/j.1326-5377.1997.tb138798.x"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/09595230220119363","volume":"21","author":"Gowing","year":"2002","unstructured":"Gowing LR, Henry-Edwards SM, Irvine RJ, Ali RL (2002) The health effects of ecstasy: a literature review. Drug Alcohol Rev 21:53?63","journal-title":"Drug Alcohol Rev"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4065\/78.5.603","volume":"78","author":"Charkoudian","year":"2003","unstructured":"Charkoudian N (2003) Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clin Proc 78:603?612","journal-title":"Mayo Clin Proc"},{"key":"CR20","doi-asserted-by":"crossref","unstructured":"Screaton GR, Singer M, Cairns HS, Thrasher A, Sarner M, Cohen SL (1992) Hyperpyrexia and rhabdomyolysis after MDMA (?ecstasy?) abuse. Lancet 339 677?678","DOI":"10.1016\/0140-6736(92)90834-P"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bmj.305.6844.29","volume":"305","author":"Fahal","year":"1992","unstructured":"Fahal IH, Sallomi DF, Yaqoob M, Bell GM (1992) Acute renal failure after ecstasy. BMJ 305:29","journal-title":"BMJ"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0196-0644(98)70018-6","volume":"32","author":"Mueller","year":"1998","unstructured":"Mueller PD, Korey WS (1998) Death by ?ecstasy?: the serotonin syndrome? Ann Emerg Med 32:377?380","journal-title":"Ann Emerg Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1542\/peds.100.4.705","volume":"100","author":"Schwartz","year":"1997","unstructured":"Schwartz RH, Miller NS (1997) MDMA (ecstasy) and the rave: a review. Pediatrics 100:705?788","journal-title":"Pediatrics"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jcp.49.2.149","volume":"49","author":"Milroy","year":"1996","unstructured":"Milroy CM, Clark JC, Forrest AR (1996) Pathology of deaths associated with ?ecstasy? and ?eve? misuse. J Clin Pathol 49:149?153","journal-title":"J Clin Pathol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/archinte.1981.00340120115023","volume":"141","author":"Simpson","year":"1981","unstructured":"Simpson DL, Rumack BH (1981) Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology. Arch Intern Med 141:1507?1509","journal-title":"Arch Intern Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2044.1993.tb07423.x","volume":"48","author":"Nimmo","year":"1993","unstructured":"Nimmo SM, Kennedy BW, Tullett WM, Blyth AS, Dougall JR (1993) Drug-induced hyperthermia. Anaesthesia 48:892?895","journal-title":"Anaesthesia"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jama.1935.02760310006002","volume":"105","author":"Tainter","year":"1935","unstructured":"Tainter ML, Stockton AB et al (1935) Dinitrophenol in the treatment of obesity. JAMA 105:332?337","journal-title":"JAMA"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.1933.02740420053027","volume":"101","author":"Geiger","year":"1933","unstructured":"Geiger JC (1933) A death from alpha-dinitrophenol poisoning. JAMA 101:1333","journal-title":"JAMA"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.1934.02750140027011","volume":"102","author":"Poole","year":"1934","unstructured":"Poole FE, Haining RB (1934) Sudden death from dinitrophenol poisoning. JAMA 102:1141?1146","journal-title":"JAMA"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jama.1934.02750140033012","volume":"102","author":"Tainter","year":"1934","unstructured":"Tainter ML, Wood DA (1934) A case of fatal dinitrophenol poisoning. JAMA 102:1147?1149","journal-title":"JAMA"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/bmj.1.5080.1156","volume":"11","author":"Memon","year":"1958","unstructured":"Memon JA (1958) Tropical hazards associated with the use of pentachlorophenol. BMJ 11:1156?1158","journal-title":"BMJ"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00007611-198202000-00016","volume":"75","author":"Leftwich","year":"1982","unstructured":"Leftwich RB, Floro JF, Neal RA, Wood AJ (1982) Dinitrophenol poisoning: a diagnosis to consider in undiagnosed fever. South Med J 75:182?184","journal-title":"South Med J"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00139709-200322010-00002","volume":"22","author":"Proudfoot","year":"2003","unstructured":"Proudfoot AT (2003) Pentachlorophenol poisoning. Toxicol Rev 22:3?11","journal-title":"Toxicol Rev"},{"key":"CR34","first-page":"527","volume":"25","author":"Wood","year":"1983","unstructured":"Wood S, Rom WN, White GL Jr, Logan DC (1983) Pentachlorophenol poisoning. J Occup Med 25:527?530","journal-title":"J Occup Med"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/00039896.1985.10545910","volume":"40","author":"Gray","year":"1985","unstructured":"Gray RE, Gilliland RD, Smith EE, Lockard VG, Hume AS (1985) Pentachlorophenol intoxication: report of a fatal case, with comments on the clinical course and pathologic anatomy. Arch Environ Health 40:161?164","journal-title":"Arch Environ Health"},{"key":"CR36","doi-asserted-by":"crossref","unstructured":"Parascandola J (1974) Dinitrophenol and bioenergetics: an historical perspective. Mol Cell Biochem 5 (1?2):69?77","DOI":"10.1007\/BF01874175"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.pharmtox.40.1.353","volume":"40","author":"Wallace","year":"2000","unstructured":"Wallace KB, Starkov AA (2000) Mitochondrial targets of drug toxicity. Annu Rev Pharmacol Toxicol 40:353?388","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1365-2044.1993.tb07526.x","volume":"48","author":"Watson","year":"1993","unstructured":"Watson JD, Ferguson C, Hinds CJ, Skinner R, Coakley JH (1993) Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place? Anaesthesia 48:1057?1060","journal-title":"Anaesthesia"},{"key":"CR39","first-page":"136","volume":"10","author":"Mason","year":"1965","unstructured":"Mason MF, Wallace SM, Foerster E, Drummond W (1965) Pentachlorophenol poisoning: report of two cases. J Forensic Sci 10:136?147","journal-title":"J Forensic Sci"},{"key":"CR40","unstructured":"Denborough MA, Hopkinson KC (1997) Dantrolene and ?ecstasy.? Med J Aust 166:165?166"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(91)90288-D","volume":"38","author":"Gordon","year":"1991","unstructured":"Gordon CJ, Watkinson WP, O?Callaghan JP, Miller DB (1991) Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav 38:339?344","journal-title":"Pharmacol Biochem Behav"},{"key":"CR42","first-page":"478","volume":"255","author":"Schmidt","year":"1990","unstructured":"Schmidt CJ, Abbate GM, Black CK, Taylor VL (1990) Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methyldioxymethamphetamine in rats. J Pharmacol Exp Ther 255:478?483","journal-title":"J Pharmacol Exp Ther"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0306-4522(99)00049-4","volume":"92","author":"Stephenson","year":"1999","unstructured":"Stephenson CP, Hunt GE, Topple AN, McGregor IS (1999) The distribution of 3,4-methylenedioxymethamphetamine ?ecstasy?-induced c-fos expression in rat brain. Neuroscience 92:1011?1023","journal-title":"Neuroscience"},{"key":"CR44","first-page":"1","volume":"8","author":"Rothwell","year":"1994","unstructured":"Rothwell NJ (1994) CNS regulation of thermogenesis. Crit Rev Neurobiol 8:1?10","journal-title":"Crit Rev Neurobiol"},{"key":"CR45","doi-asserted-by":"crossref","unstructured":"Cox B, Lee TF (1980) Further evidence for a physiological role for hypothalamic dopamine in the thermoregulation in the rat. J Physiol (Lond) 300:1?17","DOI":"10.1113\/jphysiol.1980.sp013147"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0028-3908(02)00016-3","volume":"42","author":"Mallick","year":"2002","unstructured":"Mallick BN, Jha SK, Islam F (2002) Presence of alpha-1 adrenoreceptors on thermosensitive neurons in the medial preoptico-anterior hypothalamic area in rats. Neuropharmacol 42:697?705","journal-title":"Neuropharmacol"},{"key":"CR47","first-page":"1","volume":"240","author":"Schmidt","year":"1987","unstructured":"Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1?7","journal-title":"J Pharmacol Exp Ther"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1471-4159.1990.tb02358.x","volume":"54","author":"Nash","year":"1990","unstructured":"Nash JF, Meltzer HY, Gudelsky GA (1990) Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens. J Neurochem 54:1062?1067","journal-title":"J Neurochem"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704442","volume":"135","author":"Mechan","year":"2002","unstructured":"Mechan AO, Esteban B, O?Shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) to rats. Br J Pharmacol 135:170?180","journal-title":"Br J Pharmacol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bjp.0704094","volume":"133","author":"McDaid","year":"2001","unstructured":"McDaid J, Docherty JR (2001) Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat. Br J Pharmacol 133:429?437","journal-title":"Br J Pharmacol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/0006-2952(87)90594-6","volume":"36","author":"Steele","year":"1987","unstructured":"Steele TD, Nichols DE, Yim GKW (1987) Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]-monoamines into synaptosomes from different regions of rat brain. Biochem Pharmacol 36:2297?2303","journal-title":"Biochem Pharmacol"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-0348-5559-4_14","volume":"32","author":"Himms-Hagen","year":"1978","unstructured":"Himms-Hagen J, Cerf J, Desautels M, Zaror-Behrens G (1978) Thermogenic mechanisms and their control. Experientia Suppl 32:119?134","journal-title":"Experientia Suppl"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-5793(80)80613-2","volume":"113","author":"Lin","year":"1980","unstructured":"Lin CS, Klingenberg M (1980) Isolation of the uncoupling protein from brown adipose tissue mitochondria. FEBS Lett 113:299?303","journal-title":"FEBS Lett"},{"key":"CR54","first-page":"65","volume":"Pract","author":"Simon","year":"1994","unstructured":"Simon HB (1994) Hyperthermia and heatstroke. Hosp Pract (Off Ed) 29:65?68","journal-title":"Hosp"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0006-291X(82)91150-0","volume":"106","author":"Ricquier","year":"1982","unstructured":"Ricquier D, Lin C, Klingenberg M (1982) Isolation of the GDP binding protein from brown adipose tissue mitochondria of several animals and amino acid composition study in rat. Biochem Biophys Res Commun 106:582?589","journal-title":"Biochem Biophys Res Commun"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1152\/physrev.1969.49.2.330","volume":"49","author":"Smith","year":"1969","unstructured":"Smith RE, Horwitz BA (1969) Brown fat and thermogenesis. Physiol Rev 49:330?425","journal-title":"Physiol Rev"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0014-5793(94)80599-7","volume":"343","author":"Jezek","year":"1994","unstructured":"Jezek P, Freisleben HJ (1994) Fatty acid binding site of the mitochondrial uncoupling protein. Demonstration of its existence by EPR spectroscopy of 5-DOXYL-stearic acid. FEBS Lett 343:22?26","journal-title":"FEBS Lett"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"29385","DOI":"10.1074\/jbc.R300011200","volume":"278","author":"Lowell","year":"2003","unstructured":"Lowell BB, Bachman ES (2003) Beta-adrenergic receptors, diet-induced thermogenesis, and obesity. J Biol Chem 278:29385?29388","journal-title":"J Biol Chem"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"32847","DOI":"10.1074\/jbc.272.52.32847","volume":"272","author":"Zhao","year":"1997","unstructured":"Zhao J, Cannon B, Nedergaard J (1997) Alpha1-Adrenergic stimulation potentiates the thermogenic action of beta3-adrenoreceptor-generated cAMP in brown fat cells. J Biol Chem 272:32847?32856","journal-title":"J Biol Chem"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0003-9861(72)90490-0","volume":"151","author":"Nicholls","year":"1972","unstructured":"Nicholls P, Wenner CE (1972) Release of respiratory control by uncouplers: the question of stoichiometry. Arch Biochem Biophys 151:206?215","journal-title":"Arch Biochem Biophys"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0163-7827(89)90009-X","volume":"28","author":"Himms-Hagen","year":"1989","unstructured":"Himms-Hagen J (1989) Brown adipose tissue thermogenesis and obesity. Prog Lipid Res 28:67?115","journal-title":"Prog Lipid Res"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0005-2728(94)90099-X","volume":"1187","author":"Brand","year":"1994","unstructured":"Brand MD, Chien LF, Ainscow EK, Rolfe DF, Porter RK (1994) The causes and functions of mitochondrial proton leak. Biochim Biophys Acta 1187:132?139","journal-title":"Biochim Biophys Acta"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"C1380","DOI":"10.1152\/ajpcell.1996.271.4.C1380","volume":"271","author":"Rolfe","year":"1996","unstructured":"Rolfe DF, Brand MD (1996) Contribution of mitochondrial proton leak to skeletal muscle respiration and to standard metabolic rate. Am J Physiol 271:C1380?C1389","journal-title":"Am J Physiol"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng0397-269","volume":"15","author":"Fleury","year":"1997","unstructured":"Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH (1997) Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269?372","journal-title":"Nat Genet"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-5793(97)00384-0","volume":"408","author":"Boss","year":"1997","unstructured":"Boss O, Samec S, Paoloni-Giacobino A, Rossier C, Dulloo A, Seydoux J, Muzzin P, Giacobino JP (1997) Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 408:39?42","journal-title":"FEBS Lett"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1997.6740","volume":"235","author":"Vidal-Puig","year":"1997","unstructured":"Vidal-Puig A, Solanes G, Grujic D, Flier JS, Lowell BB (1997) UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun 235:79?82","journal-title":"Biochem Biophys Res Commun"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/diabetes.49.2.143","volume":"49","author":"Boss","year":"2000","unstructured":"Boss O, Hagen T, Lowell BB (2000) Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes 49:143?156","journal-title":"Diabetes"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-5793(97)00755-2","volume":"412","author":"Boss","year":"1997","unstructured":"Boss O, Samec S, Paoloni-Giacobino A, Rossier C, Dulloo A, Seydoux J, Muzzin P, Giacobino JP (1997) Tissue-dependent upregulation of rat uncoupling protein-2 expression in response to fasting or cold. FEBS Lett 412:111?114","journal-title":"FEBS Lett"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/(SICI)1096-9861(19980810)397:4<549::AID-CNE7>3.0.CO;2-1","volume":"397","author":"Richard","year":"1998","unstructured":"Richard D, Rivest R, Huang Q, Bouillaud F, Sanchis D, Champigny O, Ricquier D (1998) Distribution of the uncoupling protein 2 mRNA in the mouse brain. J Comp Neurol 397:549?560","journal-title":"J Comp Neurol"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-5793(01)02338-9","volume":"495","author":"Hanak","year":"2001","unstructured":"Hanak P, Jezek P (2001) Mitochondrial uncoupling proteins and phylogenesis-UCP4 as the ancestral uncoupling protein. FEBS Lett 495:137?141","journal-title":"FEBS Lett"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"34611","DOI":"10.1074\/jbc.273.51.34611","volume":"273","author":"Sanchis","year":"1998","unstructured":"Sanchis D, Fleury C, Chomiki N, Goubern M, Huang Q, Neverova M, Gregoire F, Easlick J, Raimbault S, Levi-Meyrueis C, Miroux B, Collins S, Seldin M, Richard D, Warden C, Bouillaud F, Ricquier D (1998) BMCP1, a novel mitochondrial carrier with high expression in the central nervous system of humans and rodents, and respiration uncoupling activity in recombinant yeast. J Biol Chem 273:34611?34615","journal-title":"J Biol Chem"},{"key":"CR72","doi-asserted-by":"crossref","unstructured":"Reitman ML, He Y, Gong DW (1999) Thyroid hormone and other regulators of uncoupling proteins. Int J Obes Relat Metab Disord 23 [Suppl 6]:S56?S59","DOI":"10.1038\/sj.ijo.0800948"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/bbrc.1999.0530","volume":"258","author":"Acin","year":"1999","unstructured":"Acin A, Rodriguez M, Rique H, Canet E, Boutin JA, Galizzi JP (1999) Cloning and characterization of the 5? flanking region of the human uncoupling protein 3 (UCP3) gene. Biochem Biophys Res Commun 258:278?283","journal-title":"Biochem Biophys Res Commun"},{"key":"CR74","doi-asserted-by":"crossref","first-page":"47129","DOI":"10.1074\/jbc.M208262200","volume":"277","author":"Echtay","year":"2002","unstructured":"Echtay KS, Murphy MP, Smith RA, Talbot DA, Brand MD (2002) Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem 277:47129?47135","journal-title":"J Biol Chem"},{"key":"CR75","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1093\/emboj\/cdg412","volume":"22","author":"Echtay","year":"2003","unstructured":"Echtay KS, Esteves TC, Pakay JL, Jekabsons MB, Lambert AJ, Portero-Otin M, Pamplona R, Vidal-Puig AJ, Wang S, Roebuck SJ, Brand MD (2003) A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 22:4103?4110","journal-title":"EMBO J"},{"key":"CR76","doi-asserted-by":"crossref","first-page":"48534","DOI":"10.1074\/jbc.M308529200","volume":"278","author":"Murphy","year":"2003","unstructured":"Murphy MP, Echtay KS, Blaikie FH, Asin-Cayuela J, Cocheme HM, Green K, Buckingham JA, Taylor ER, Hurrell F, Hughes G, Miwa S, Cooper CE, Svistunenko DA, Smith RA, Brand MD (2003) Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. J Biol Chem 278:48534?48545","journal-title":"J Biol Chem"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0005-2728(90)90232-S","volume":"1018","author":"Brand","year":"1990","unstructured":"Brand MD (1990) The proton leak across the mitochondrial inner membrane. Biochim Biophys Acta 1018:128?133","journal-title":"Biochim Biophys Acta"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0065-2571(70)90013-0","volume":"8","author":"Himms-Hagen","year":"1970","unstructured":"Himms-Hagen J (1970) Regulation of metabolic processes in brown adipose tissue in relation to nonshivering thermogenesis. Adv Enzyme Regul 8:131?151","journal-title":"Adv Enzyme Regul"},{"key":"CR79","doi-asserted-by":"crossref","unstructured":"Enerback S, Jacobsson A, Simpson EM, Guerra C, Yamashita H, Harper ME, Kozak LP (1997) Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 387 90?94","DOI":"10.1038\/387090a0"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/82565","volume":"26","author":"Arsenijevic","year":"2000","unstructured":"Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, Couplan E, Alves-Guerra MC, Goubern M, Surwit R, Bouillaud F, Richard D, Collins S, Ricquier D (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26:435?439","journal-title":"Nat Genet"},{"key":"CR81","doi-asserted-by":"crossref","first-page":"16251","DOI":"10.1074\/jbc.M910177199","volume":"275","author":"Gong","year":"2000","unstructured":"Gong DW, Monemdjou S, Gavrilova O, Leon LR, Marcus-Samuels B, Chou CJ, Everett C, Kozak LP, Li C, Deng C, Harper ME, Reitman ML (2000) Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem 275:16251?16257","journal-title":"J Biol Chem"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"44784","DOI":"10.1074\/jbc.M207217200","volume":"277","author":"St-Pierre","year":"2002","unstructured":"St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD (2002) Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 277:44784?44790","journal-title":"J Biol Chem"},{"key":"CR83","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/nm903","volume":"9","author":"Mattiasson","year":"2003","unstructured":"Mattiasson G, Shamloo M, Gido G, Mathi K, Tomasevic G, Yi S, Warden CH, Castilho RF, Melcher T, Gonzalez-Zulueta M, Nikolich K, Wieloch T (2003) Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med 9:1062?1068","journal-title":"Nat Med"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0005-2728(00)00243-7","volume":"1504","author":"Stuart","year":"2001","unstructured":"Stuart JA, Cadenas S, Jekabsons MB, Roussel D, Brand MD (2001) Mitochondrial proton leak and the uncoupling protein 1 homologues. Biochim Biophys Acta 1504:144?158","journal-title":"Biochim Biophys Acta"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"27385","DOI":"10.1074\/jbc.M111860200","volume":"277","author":"Mills","year":"2002","unstructured":"Mills EM, Xu D, Fergusson MM, Combs CA, Xu Y, Finkel T (2002) Regulation of cellular oncosis by uncoupling protein 2. J Biol Chem 277:27385?27392","journal-title":"J Biol Chem"},{"key":"CR86","doi-asserted-by":"crossref","unstructured":"Mills EM, Banks ML, Sprague JE, Finkel T (2003) Pharmacology: uncoupling the agony from ecstasy. Nature 426 403?404","DOI":"10.1038\/426403a"},{"key":"CR87","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0964-3397(97)80056-0","volume":"13","author":"Cunningham","year":"1997","unstructured":"Cunningham M (1997) Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure. Intensive Crit Care Nurs 13:216?223","journal-title":"Intensive Crit Care Nurs"},{"key":"CR88","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bjp.0705823","volume":"142","author":"Sprague","year":"2004","unstructured":"Sprague JE, Brutcher RE, Mills EM, Caden D, Rusyniak DE (2004) Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) induced rhabdomyolysis with ?1-plus ?3-adrenoreceptor antagonists. Br J Pharmacol 142:667?670","journal-title":"Br J Pharmacol"},{"key":"CR89","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2337\/diabetes.48.7.1482","volume":"48","author":"Chan","year":"1999","unstructured":"Chan CB, MacDonald PE, Saleh MC, Johns DC, Marban E, Wheeler MB (1999) Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 48:1482?1486","journal-title":"Diabetes"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1074\/jbc.274.9.5692","volume":"274","author":"Chavin","year":"1999","unstructured":"Chavin KD, Yang S, Lin HZ, Chatham J, Chacko VP, Hoek JB, Walajtys-Rode E, Rashid A, Chen CH, Huang CC, Wu TC, Lane MD, Diehl AM (1999) Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 274:5692?5700","journal-title":"J Biol Chem"},{"key":"CR91","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI200319774","volume":"112","author":"Krauss","year":"2003","unstructured":"Krauss S, Zhang CY, Scorrano L, Dalgaard LT, St-Pierre J, Grey ST, Lowell BB (2003) Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 112:1831?1842","journal-title":"J Clin Invest"},{"key":"CR92","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/jpet.102.044982","volume":"305","author":"Sprague","year":"2003","unstructured":"Sprague JE, Banks ML, Cook VJ, Mills EM (2003) Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy). J Pharmacol Exp Ther 305:159?166","journal-title":"J Pharmacol Exp Ther"},{"key":"CR93","doi-asserted-by":"crossref","unstructured":"Curtin NA, Clapham JC, Barclay CJ (2002) Excess recovery heat production by isolated muscles from mice overexpressing uncoupling protein-3. J Physiol (Lond) 542:231?235","DOI":"10.1113\/jphysiol.2002.021964"},{"key":"CR94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(03)00052-4","volume":"99","author":"Brown","year":"2003","unstructured":"Brown JM, Yamamoto BK (2003) Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Ther 99:45?53","journal-title":"Pharmacol Ther"},{"key":"CR95","doi-asserted-by":"crossref","unstructured":"Rusyniak DE, Tandy SL, Hekmatyar SK, Mills EM, Smith DJ, Bansal N, Sprague JE (2004) The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine mediated skeletal muscle hyperthermia and rhabdomyolysis. J Pharmacol Exp Ther (under review)","DOI":"10.1124\/jpet.104.079236"},{"key":"CR96","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1197\/j.aem.2004.03.004","volume":"11","author":"Rusyniak","year":"2004","unstructured":"Rusyniak DE, Scruggs SL, Kamendulis LM, Sprague JE, Klaunig JE (2004) The effects of ecstasy (MDMA) on rat liver bioenergetics. Acad Emer Med 11:723?729","journal-title":"Acad Emer Med"},{"key":"CR97","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1152\/japplphysiol.00363.2003","volume":"95","author":"Zaninovich","year":"2003","unstructured":"Zaninovich AA, Rebagliati I, Raices M, Ricci C, Hagmuller K (2003) Mitochondrial respiration in muscle and liver from cold-acclimated hypothyroid rats. J Appl Physiol 95:1584?1590","journal-title":"J Appl Physiol"},{"key":"CR98","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32?41","journal-title":"Synapse"},{"key":"CR99","first-page":"259","volume":"23","author":"Stuerenburg","year":"2002","unstructured":"Stuerenburg HJ, Petersen K, Baumer T, Rosenkranz M, Buhmann C, Thomasius R (2002) Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users. Neuroendocrinol Lett 23:259?261","journal-title":"Neuroendocrinol Lett"},{"key":"CR100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI200112584","volume":"108","author":"Ribeiro","year":"2001","unstructured":"Ribeiro MO, Carvalho SD, Schultz JJ, Chiellini G, Scanlan TS, Bianco AC, Brent GA (2001) Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific. J Clin Invest 108:97?105","journal-title":"J Clin Invest"},{"key":"CR101","first-page":"E960","volume":"269","author":"Ye","year":"1995","unstructured":"Ye JM, Clark MG, Colquhoun EQ (1995) Constant-pressure perfusion of rat hindlimb shows alpha- and beta-adrenergic stimulation of oxygen consumption. Am J Physiol 269:E960?E968","journal-title":"Am J Physiol"},{"key":"CR102","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bjp.0704094","volume":"133","author":"McDaid","year":"2001","unstructured":"McDaid J, Docherty JR (2001) Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat. Br J Pharmacol 133:429?437","journal-title":"Br J Pharmacol"},{"key":"CR103","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1523\/JNEUROSCI.21-21-08648.2001","volume":"21","author":"Pedersen","year":"2001","unstructured":"Pedersen NP Blessing WW (2001) Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. J Neurosci 21:8648?8654","journal-title":"J Neurosci"},{"key":"CR104","doi-asserted-by":"crossref","first-page":"24129","DOI":"10.1074\/jbc.272.39.24129","volume":"272","author":"Gong","year":"1997","unstructured":"Gong DW, He Y, Karas M, Reitman M (1997) Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J Biol Chem 272:24129?24132","journal-title":"J Biol Chem"},{"key":"CR105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1292\/jvms.63.309","volume":"63","author":"Nakamura","year":"2001","unstructured":"Nakamura Y, Nagase I, Asano A, Sasaki N, Yoshida T, Umekawa T, Sakane N, Saito M (2001) Beta 3-adrenergic agonist up-regulates uncoupling proteins 2 and 3 in skeletal muscle of the mouse. J Vet Med Sci 63:309?314","journal-title":"J Vet Med Sci"},{"key":"CR106","first-page":"H1402","volume":"259","author":"Martin","year":"1990","unstructured":"Martin WH, Tolley TK, Saffitz JE (1990) Autoradiographic delineation of skeletal muscle alpha 1-adrenergic receptor distribution. Am J Physiol 259:H1402?H1408","journal-title":"Am J Physiol"},{"key":"CR107","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1476-5381.1993.tb13743.x","volume":"109","author":"Sillence","year":"1993","unstructured":"Sillence MN, Moore NG, Pegg GG, Lindsay DB (1993) Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes. Br J Pharmacol 109:1157?1163","journal-title":"Br J Pharmacol"},{"key":"CR108","first-page":"E960","volume":"269","author":"Ye","year":"1995","unstructured":"Ye JM, Clark MG, Colquhoun EQ (1995) Constant-pressure perfusion of rat hindlimb shows alpha- and beta-adrenergic stimulation of oxygen consumption. Am J Physiol 269:E960?E968","journal-title":"Am J Physiol"},{"key":"CR109","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.ijo.0801039","volume":"23","author":"Chamberlain","year":"1999","unstructured":"Chamberlain PD, Jennings KH, Paul F, Cordell J, Berry A, Holmes SD, Park J, Chambers J, Sennitt MV, Stock MJ, Cawthorne MA, Young PW, Murphy GJ (1999) The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 23:1057?1065","journal-title":"Int J Obes Relat Metab Disord"},{"key":"CR110","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/sj.ijo.0802148","volume":"26","author":"De","year":"2002","unstructured":"De Matteis R, Arch JR, Petroni ML, Ferrari D, Cinti S, Stock MJ (2002) Immunohistochemical identification of the beta (3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord 26:1442?1450","journal-title":"Int J Obes Relat Metab Disord"},{"key":"CR111","first-page":"E469","volume":"274","author":"Yoshida","year":"1998","unstructured":"Yoshida T, Umekaw T, Kumamoto K, Sakane N, Kogure A, Kondo M, Wakabayashi Y, Kawada T, Nagase I, Masyuki S (1998) ?3-adrenergic agonist induces a functionally active uncoupling protein in fat and slow-twitch muscle fibers. Am J Physiol 274:E469?E475","journal-title":"Am J Physiol"},{"key":"CR112","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1172\/JCI118748","volume":"97","author":"Nagase","year":"1996","unstructured":"Nagase I, Yoshida T, Kumamoto K, Umekawa T, Sakane N, Nikami H, Kawada T, Saito M (1996) Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic ?3-adrenergic agonist. J Clin Invest 97:2898?2904","journal-title":"J Clin Invest"},{"key":"CR113","doi-asserted-by":"crossref","first-page":"707","DOI":"10.7326\/0003-4819-93-5-707","volume":"93","author":"Morley","year":"1980","unstructured":"Morley JE, Shafer RB, Elson MK, Slag MF, Raleigh MJ, Brammer GL, Yuwiler A, Hershman JM (1980) Amphetamine-induced hyperthyroxinemia. Ann Intern Med 93:707?709","journal-title":"Ann Intern Med"},{"key":"CR114","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0014-5793(99)00061-7","volume":"444","author":"Lanni","year":"1999","unstructured":"Lanni A, Beneduce L, Lombardi A, Moreno M, Boss O, Muzzin P, Giacobino JP, Goglia F (1999) Expression of uncoupling protein-3 and mitochondrial activity in the transition from hypothyroid to hyperthyroid state in rat skeletal muscle. FEBS Lett 444:250?254","journal-title":"FEBS Lett"},{"key":"CR115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0014-5793(03)00320-X","volume":"543","author":"Lanni","year":"2003","unstructured":"Lanni A, Moreno M, Lombardi A, Goglia F (2003) Thyroid hormone and uncoupling proteins. FEBS Lett 543:5?10","journal-title":"FEBS Lett"},{"key":"CR116","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0005-2728(03)00057-4","volume":"1604","author":"Cunningham","year":"2003","unstructured":"Cunningham O, McElligott AM, Carroll AM, Breen E, Reguenga C, Oliveira ME, Azevedo JE, Porter RK (2003) Selective detection of UCP 3 expression in skeletal muscle: effect of thyroid status and temperature acclimation. Biochim Biophys Acta 1604:170?179","journal-title":"Biochim Biophys Acta"},{"key":"CR117","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1210\/endo.136.8.7628360","volume":"136","author":"Rubio","year":"1995","unstructured":"Rubio A, Raasmaja A, Maia AL, Kim KR, Silva JE (1995) Effects of thyroid hormone on norepinephrine signaling in brown adipose tissue. I. Beta 1- and beta 2-adrenergic receptors and cyclic adenosine 3?,5?-monophosphate generation. Endocrinol 136:3267?3276","journal-title":"Endocrinol"},{"key":"CR118","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(67)90025-8","volume":"2","author":"Dolfini","year":"1967","unstructured":"Dolfini E, Kobayashi M (1967) Studies with amphetamine in hyper-and hypothyroid rats. Eur J Pharmacol 2:65?66","journal-title":"Eur J Pharmacol"},{"key":"CR119","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/204387a0","volume":"204","author":"Halpern","year":"1964","unstructured":"Halpern BN, Drudi-Baracoo C, Bessirard D (1964) Exahtation of toxicity of sympathomimetic amines by thyroxine. Nature 204:387?388","journal-title":"Nature"},{"key":"CR120","first-page":"1339","volume":"68","author":"Sprague","year":"2004","unstructured":"Sprague JE, Mallett NM, Rusyniak DE, Mills EM (2004) UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia. Eur J Pharmacol 68:1339?1343","journal-title":"Eur J Pharmacol"},{"key":"CR121","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1074\/jbc.271.5.2615","volume":"217","author":"Garlid","year":"1996","unstructured":"Garlid KD, Orosz DE, Modriansky M, Vassanelli S, Jezek P (1996) On the mechanism of fatty acid-induced proton transport by mitochondrial uncoupling protein. J Biol Chem 217:2615?2620","journal-title":"J Biol Chem"},{"key":"CR122","unstructured":"Roberts JR, Hedges JR (1998) Clinical procedures in emergency medicine, 3rd edn. Saunders, Philadelphia"},{"key":"CR123","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1523\/JNEUROSCI.23-15-06385.2003","volume":"23","author":"Blessing","year":"2003","unstructured":"Blessing WW, Seaman B, Pedersen NP, Ootsuka Y (2003) Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats. J Neurosci 23:6385?6391","journal-title":"J Neurosci"},{"key":"CR124","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","volume":"324","author":"Baldessarini","year":"1991","unstructured":"Baldessarini RJ, Frankenburg FR (1991) Clozapine. A novel antipsychotic agent. N Engl J Med 324:746?754","journal-title":"N Engl J Med"},{"key":"CR125","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704442","volume":"135","author":"Mechan","year":"2002","unstructured":"Mechan AO, Esteban B, O?Shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) to rats. Br J Pharmacol 135:170?180","journal-title":"Br J Pharmacol"},{"key":"CR126","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1471-4159.1990.tb02358.x","volume":"54","author":"Nash","year":"1990","unstructured":"Nash JF, Meltzer HY, Gudelsky GA (1990) Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens. J Neurochem 54:1062?1067","journal-title":"J Neurochem"},{"key":"CR127","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0306-4522(02)00810-2","volume":"117","author":"Blessing","year":"2003","unstructured":"Blessing WW, Seaman B (2003) 5-Hydroxytryptamine (2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats. Neuroscience 117:939?948","journal-title":"Neuroscience"},{"key":"CR128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-73-1-81","volume":"73","author":"Ginsberg","year":"1970","unstructured":"Ginsberg MD, Hertzman M, Schmidt-Nowara WW (1970) Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke. Ann Intern Med 73:81?85","journal-title":"Ann Intern Med"},{"key":"CR129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/0003-4819-86-4-381","volume":"86","author":"Kendrick","year":"1977","unstructured":"Kendrick WC, Hull AR, Knochel JP (1977) Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med 86:381?387","journal-title":"Ann Intern Med"},{"key":"CR130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0735-6757(84)90178-5","volume":"2","author":"Roberts","year":"1984","unstructured":"Roberts JR, Quattrocchi E, Howland MA (1984) Severe hyperthermia secondary to intravenous drug abuse. Am J Emerg Med 2:373","journal-title":"Am J Emerg Med"},{"key":"CR131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0196-0644(94)70165-2","volume":"24","author":"Callaway","year":"1994","unstructured":"Callaway CW, Clark RF (1994) Hyperthermia in psychostimulant overdose. Ann Emerg Med 24:68?76","journal-title":"Ann Emerg Med"},{"key":"CR132","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0028-3908(84)90136-9","volume":"23","author":"Vogel","year":"1984","unstructured":"Vogel WH, Miller J, DeTurck KH, Routzahn BK Jr (1984) Effects of psychoactive drugs on plasma catecholamines during stress in rats. Neuropharmacology 23:1105?1108","journal-title":"Neuropharmacology"},{"key":"CR133","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0091-3057(01)00482-8","volume":"68","author":"Sofuoglu","year":"2001","unstructured":"Sofuoglu M, Nelson D, Babb DA, Hatsukami DK (2001) Intravenous cocaine increases plasma epinephrine and norepinephrine in humans. Pharmacol Biochem Behav 68:455?459","journal-title":"Pharmacol Biochem Behav"},{"key":"CR134","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(98)00758-4","volume":"363","author":"Makisumi","year":"1998","unstructured":"Makisumi T, Yoshida K, Watanabe T, Tan N, Murakami N, Morimoto A (1998) Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism. Eur J Pharmacol 363:107?112","journal-title":"Eur J Pharmacol"},{"key":"CR135","first-page":"148","volume":"205","author":"Chiueh","year":"1978","unstructured":"Chiueh CC, Kopin IJ (1978) Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats. J Pharmacol Exp Ther 205:148?154","journal-title":"J Pharmacol Exp Ther"},{"key":"CR136","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0091-3057(93)90518-X","volume":"45","author":"Swerdlow","year":"1993","unstructured":"Swerdlow NR, Koob GF, Cador M, Lorang M, Hauger RL (1993) Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacol Biochem Behav 45:629?637","journal-title":"Pharmacol Biochem Behav"},{"key":"CR137","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0196-0644(98)70018-6","volume":"32","author":"Mueller","year":"1998","unstructured":"Mueller PD, Korey WS (1998) Death by ?ecstasy?: the serotonin syndrome? Ann Emerg Med 32:377?380","journal-title":"Ann Emerg Med"},{"key":"CR138","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0749-0704(05)70368-7","volume":"13","author":"Mills","year":"1997","unstructured":"Mills KC (1997) Serotonin syndrome. A clinical update. Crit Care Clin 13:763?783","journal-title":"Crit Care Clin"},{"key":"CR139","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0140-6736(93)92774-N","volume":"342","author":"Neuvonen","year":"1993","unstructured":"Neuvonen PJ, Pohjola-Sintonen S, Tacke U, Vuori E (1993) Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses. Lancet 342:1419","journal-title":"Lancet"},{"key":"CR140","doi-asserted-by":"crossref","unstructured":"Mason PJ, Morris VA, Balcezak TJ (2000) Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine (Baltimore) 79:201?209","DOI":"10.1097\/00005792-200007000-00001"},{"key":"CR141","doi-asserted-by":"crossref","unstructured":"Nisijima K, Yoshino T, Ishiguro T (2000) Risperidone counteracts lethality in an animal model of the serotonin syndrome. Psychopharmacology (Berl) 150:9?14","DOI":"10.1007\/s002130000397"},{"key":"CR142","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0197-0186(02)00213-9","volume":"43","author":"Nisijima","year":"2003","unstructured":"Nisijima K, Shioda K, Yoshino T, Takano K, Kato S (2003) Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochem Int 43:155?164","journal-title":"Neurochem Int"},{"key":"CR143","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00004714-200002000-00022","volume":"20","author":"Nisijima","year":"2000","unstructured":"Nisijima K (2000) Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndrome. J Clin Psychopharmacol 20:107?108","journal-title":"J Clin Psychopharmacol"},{"key":"CR144","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.jcp.0000088920.02635.5a","volume":"23","author":"Nisijima","year":"2003","unstructured":"Nisijima K, Nibuya M, Sugiyama H (2003) Abnormal CSF monoamine metabolism in serotonin syndrome. J Clin Psychopharmacol 23:528?531","journal-title":"J Clin Psychopharmacol"},{"key":"CR145","first-page":"918","volume":"270","author":"Welch","year":"1994","unstructured":"Welch JE, Saphier D (1994) Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist (+-)-1-(2:5-dimethoxy-4-iodophenyl)-2-aminopropane. J Pharmacol Exp Ther 270:918?928","journal-title":"J Pharmacol Exp Ther"},{"key":"CR146","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0031-3955(16)38700-4","volume":"41","author":"Kaus","year":"1994","unstructured":"Kaus SJ, Rockoff MA (1994) Malignant hyperthermia. Pediatr Clin North Am 41:221?237","journal-title":"Pediatr Clin North Am"},{"key":"CR147","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1399-6576.1990.tb03172.x","volume":"34","author":"Haggendal","year":"1990","unstructured":"Haggendal J, Jonsson L, Carlsten J (1990) The role of sympathetic activity in initiating malignant hyperthermia. Acta Anaesthesiol Scand 34:677?682","journal-title":"Acta Anaesthesiol Scand"},{"key":"CR148","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-4347(00)82008-3","volume":"344","author":"Williams","year":"1985","unstructured":"Williams CH, Dozier SE, Buzello W, Gehrke CW, Wong JK, Gerhardt KO (1985) Plasma levels of norepinephrine and epinephrine during malignant hyperthermia in susceptible pigs. J Chromatogr 344:71?80","journal-title":"J Chromatogr"},{"key":"CR149","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/bja\/48.9.831","volume":"48","author":"Lister","year":"1976","unstructured":"Lister D, Hall GM, Lucke JN (1976) Porcine malignant hyperthermia. III. Adrenergic blockade. Br J Anaesth 48:831?838","journal-title":"Br J Anaesth"},{"key":"CR150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-2999(92)90016-W","volume":"220","author":"Gerdes","year":"1992","unstructured":"Gerdes C, Richter A, Annies R, Loscher W (1992) Increase of serotonin in plasma during onset of halothane-induced malignant hyperthermia in pigs. Eur J Pharmacol 220:91?94","journal-title":"Eur J Pharmacol"},{"key":"CR151","first-page":"483","volume":"341","author":"Loscher","year":"1990","unstructured":"Loscher W, Witte U, Fredow G, Ganter M, Bickhardt K (1990) Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia. Naunyn Schmiedebergs Arch Pharmacol 341:483?493","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR152","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000542-200311000-00020","volume":"99","author":"Fiege","year":"2003","unstructured":"Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Menge M, Schulte Am Esch J (2003) Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine (?ecstasy?). Anesthesiology 99:1132?1136","journal-title":"Anesthesiology"},{"key":"CR153","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/bja\/aeg172","volume":"91","author":"Gerbershagen","year":"2003","unstructured":"Gerbershagen MU, Wappler F, Fiege M, Kolodzie K, Weisshorn R, Szafarczyk W, Kudlik C, Schulte Am Esch J (2003) Effects of a 5HT (2) receptor agonist on anaesthetized pigs susceptible to malignant hyperthermia. Br J Anaesth 91:281?284","journal-title":"Br J Anaesth"},{"key":"CR154","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00178953","volume":"350","author":"Loscher","year":"1994","unstructured":"Loscher W, Gerdes C, Richter A (1994) Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia. Naunyn Schmiedebergs Arch Pharmacol 350:365?374","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/bja\/50.3.241","volume":"50","author":"Lucke","year":"1978","unstructured":"Lucke JN, Denny H, Hall GM, Lovell R, Lister D (1978) Porcine malignant hyperthermia. VI. The effects of bilateral adrenalectomy and pretreatment with bretylium on the halothane-induced response. Br J Anaesth 50:241?246","journal-title":"Br J Anaesth"},{"key":"CR156","first-page":"790","volume":"82","author":"Maccani","year":"1996","unstructured":"Maccani RM, Wedel DJ, Hofer RE (1996) Norepinephrine does not potentiate porcine malignant hyperthermia. Anesth Analg 82:790?795","journal-title":"Anesth Analg"},{"key":"CR157","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/clpt.1991.184","volume":"50","author":"Nierenberg","year":"1991","unstructured":"Nierenberg D, Disch M, Manheimer E, Patterson J, Ross J, Silvestri G, Summerhill E (1991) Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome. Clin Pharmacol Ther 50:580?586","journal-title":"Clin Pharmacol Ther"},{"key":"CR158","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.31.2.132","volume":"31","author":"Henderson","year":"1981","unstructured":"Henderson VW, Wooten GF (1981) Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade? Neurology 31:132?137","journal-title":"Neurology"},{"key":"CR159","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/ajp.156.2.169","volume":"156","author":"Gurrera","year":"1999","unstructured":"Gurrera RJ (1999) Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. Am J Psychiatry 156:169?180","journal-title":"Am J Psychiatry"},{"key":"CR160","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1176\/ajp.138.8.1115","volume":"138","author":"Feibel","year":"1981","unstructured":"Feibel JH, Schiffer RB (1981) Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case report. Am J Psychiatry 138:1115?1116","journal-title":"Am J Psychiatry"},{"key":"CR161","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0022-3956(95)00007-R","volume":"29","author":"Nisijima","year":"1995","unstructured":"Nisijima K, Ishiguro T (1995) Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome. J Psychiatr Res 29:233?244","journal-title":"J Psychiatr Res"},{"key":"CR162","first-page":"258","volume":"278","author":"Malberg","year":"1996","unstructured":"Malberg JE, Sabol KE, Seiden LS (1996) Co-administration of MDMA with drugs that protect against MDMA neurotxicity produces different effects on body temperature in the rat. J Pharmacol Exp Ther 278:258?267","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-004-0591-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-004-0591-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-004-0591-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T02:40:44Z","timestamp":1682822444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-004-0591-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,10]]},"references-count":162,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1007\/s00109-004-0591-7","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,10]]}}}